-
Mashup Score: 4
“Sibling” of original may extend Omicron surges but no evidence yet it causes more severe disease
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 3After Omicron, some scientists foresee ‘a period of quiet’ - 2 year(s) ago
The variant’s modest toll in many countries has led to a sense of optimism. But new surprises are likely
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet-
Although the #OmicronVariant has sickened huge numbers of people, caused massive disruption, and left many health care workers exhausted, it is also leaving something unusual in its wake: a sense of optimism about the #COVID19 pandemic’s trajectory. https://t.co/vku7ZKcQqZ
-
-
Mashup Score: 4
A mutated version of the Omicron variant could slow the steep decline in cases, but it is not likely to change the overall course of the pandemic, scientists said.
Source: www.nytimes.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
‘Stealth’ #OmicronVariant No Cause for Alarm, but Could Slow Case Decline https://t.co/P3HDEjOB67 @nytimes https://t.co/XPf0fa3COu
-
-
Mashup Score: 2After Omicron, some scientists foresee ‘a period of quiet’ - 2 year(s) ago
The variant’s modest toll in many countries has led to a sense of optimism. But new surprises are likely
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet-
Although the #OmicronVariant has sickened huge numbers of people, caused massive disruption, and left many health care workers exhausted, it is also leaving something unusual in its wake: a sense of optimism about the #COVID19 pandemic’s trajectory. https://t.co/dKlBQf8RWq
-
-
Mashup Score: 0
The FDA cited monoclonal antibodies as being less effective against the Omicron variant in their decision to rescind their earlier approval of the COVID-19 treatment.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
#ICYMI: The #FDA cited monoclonal antibodies as being less effective against the #OmicronVariant in their decision to rescind approval of the COVID-19 treatment. https://t.co/xuACPMD0bG
-
-
Mashup Score: 18After Omicron, some scientists foresee ‘a period of quiet’ - 2 year(s) ago
The variant’s modest toll in many countries has led to a sense of optimism. But new surprises are likely
Source: www.science.orgCategories: Future of Medicine, Latest HeadlinesTweet-
Although the #OmicronVariant has sickened huge numbers of people, caused massive disruption, and left many health care workers exhausted, it is also leaving something unusual in its wake: a sense of optimism about the #COVID19 pandemic’s trajectory. https://t.co/dKlBQf8RWq
-
-
Mashup Score: 10Omicron (BA.1) SARS-CoV-2 variant is associated with reduced risk of hospitalization and length of stay compared with Delta (B.1.617.2) - 2 year(s) ago
Introduction Early reports showed that Omicron (BA.1) SARS-CoV-2 could be less severe. However, the magnitude of risk reduction of hospitalization and mortality of Omicron (BA.1) infections compared with Delta (B.1.617.2) is not yet clear. This study compares the risk of severe disease among patients infected with the Omicron (BA.1) variant with patients infected with Delta (B.1.617.2) variant in…
Source: medRxivCategories: Hem/Oncs, Latest HeadlinesTweet-
#COVID19 lessons from Portugal: Compared to #Delta, the #OmicronVariant results in 75% lower hospitalizations. Vaccinations that include boosters reduce hospitalizations by >90% @VincentRK @NarjustDumaMD @ZiadBakouny @DrLindaMD @NancyLapid @JacqEHoward https://t.co/jWFmtzmeIv https://t.co/5FWDe5x4OG
-
-
Mashup Score: 95Effectiveness of a Third Dose of mRNA Vaccines ... - 2 year(s) ago
This report describes COVID-19 vaccine effectiveness time frames among people who received their first and second doses of the vaccine series, and effectiveness of third vaccine doses during both Delta- and Omicron-predominant periods.
Categories: Healthcare Professionals, Latest HeadlinesTweet-
NEW: Today's @CDCMMWR study found that during periods of both #DeltaVariant and #OmicronVariant, a 3rd dose was highly effective at preventing #COVID19 associated emergency department visits, urgent care visits & hospitalizations. https://t.co/X8chSXviW7 https://t.co/OMtvSgZU1J
-
-
Mashup Score: 50COVID Data Tracker - 2 year(s) ago
CDC’s home for COVID-19 data. Visualizations, graphs, and data in one easy-to-use website.
Categories: Healthcare Professionals, Latest HeadlinesTweet-
Another @CDCMMWR study out today found that when the #OmicronVariant was first circulating in the United States, adults who got a #COVID19 booster dose had 5x the protection against infection compared with adults who were not vaccinated. https://t.co/EXj2fbrpBM https://t.co/pXPAGMQino
-
-
Mashup Score: 9Study identifies mutations specific to omicron variant - 2 year(s) ago
While the omicron variant continues to infect people around the world, researchers at the University of Missouri have identified the highly prevalent, specific mutations that are causing the omicron variant’s high rate of infection.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
Study identifies #mutations specific to #omicronvariant @MizzouNews https://t.co/cRHcUdsHDF
-
Scientists are now trying to make sense of why BA.2, a related strain of the #OmicronVariant, is exploding and what its emergence means. https://t.co/W1Bx0JGlv5